Sprintec Kit
Product Images NDC 68788-7429

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sprintec (NDC 68788-7429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister Image (Image 1)

Sprintec 28-day oral contraceptive kit label showing a blister pack layout with days of the week (Sunday to Saturday) across the top and four rows labeled Week 1 through Week 4. The first three rows have 21 gray tablets representing active pills, while the fourth row has 7 white tablets representing inactive pills. The label includes the generic names norgestimate and ethinyl estradiol with strengths of 0.250 mg and 0.035 mg respectively, plus storage instructions.*

FDA Label Image

Norgestimate Structural Formula (Image 2)

Chemical structure of Norgestimate, a component of Sprintec (Norgestimate and Ethinyl Estradiol). The diagram shows the molecular arrangement of atoms and bonds in the Norgestimate molecule, as labeled in the image.*

FDA Label Image

Ethinyl Estradiol Structural Formaula (Image 3)

Chemical structure of Ethinyl Estradiol depicted with labeled functional groups including hydroxyl and alkyne moieties, as part of the active ingredients in Sprintec.*

FDA Label Image

Fewer-more Pregnancies Image (Image 4)

A chart displaying birth control effectiveness related to pregnancy rates per 100 women per year. It categorizes methods ranging from implants, injections, and sterilization with fewer than 1 pregnancy, to birth control pills, skin patches, and vaginal rings with hormones, then condoms and diaphragms, followed by behavioral methods like abstinence during fertile days, spermicides, and withdrawal, and finally no birth control with the highest pregnancy rates.*

FDA Label Image

Blister Image (Image 5)

Sprintec 28-day oral contraceptive kit label showing a blister pack layout with 28 circular pill positions arranged in four rows by seven columns, labeled with days of the week (Sunday to Saturday) and weeks (Week 1 to Week 4). The kit includes norgestimate and ethinyl estradiol tablets, 0.250 mg/0.035 mg dosage. Instructions indicate taking all colored pills before any white pills, with storage information at 20° to 25°C (68° to 77°F).*

FDA Label Image

Sprintec Tablets 0.250mg/0.035mg (Image 6)

Sprintec Tablets 0.250 mg/0.035 mg kit packaging label. The label includes the generic name Norgestimate and Ethinyl Estradiol, manufacturer Teva Pharmaceuticals USA Inc., and labeler Preferred Pharmaceuticals, Inc. It contains directions for use in English and Spanish, a QR code, and regulatory cautions about prescription-only use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.